Boehringer Ingelheim acquires SSP (エスエス製薬), acquiring remaining 40% for US$ 365 million

Boehringer Ingelheim acquisition values SSP at approx US$ 900 million Boehringer Ingelheim acquires SSP stage-by-stage: 9.2% in 1996, 60% in 2001, 100% in 2010 Boehringer Ingelheim acquires SSP (エスエス製薬株式会社), a Japanese OTC pharma company founded originally in 1765 as a pharmacy in Yaesu, Tokyo, starting with business cooperation, followed by staged investment over a period […]

(c)2009-2018 Eurotechnology Japan KK All Rights Reserved.